Vecamyl (Turing Pharmaceuticals)


Welcome to the PulseAid listing for the Vecamyl drug offered from Turing Pharmaceuticals. This Autonomic Ganglionic Blocker [EPC],Decreased Autonomic Ganglionic Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Turing Pharmaceuticals
NON-PROPRIETARY NAME: Mecamylamine Hydrochloride
SUBSTANCE NAME: MECAMYLAMINE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Autonomic Ganglionic Blocker [EPC],Decreased Autonomic Ganglionic Activity [PE]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2013-03-19
END MARKETING DATE: 0000-00-00


Vecamyl HUMAN PRESCRIPTION DRUG Details:

Item DescriptionVecamyl from Turing Pharmaceuticals
LABELER NAME: Turing Pharmaceuticals
DEA SCHEDULE:
ACTIVE STRENGTH: 2.5(mg/1)
START MARKETING DATE: 2013-03-19
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69413-558_6d7d4f9f-6aad-407c-9565-a9800a2ac1aa
PRODUCT NDC: 69413-558
APPLICATION NUMBER: ANDA204054

Other MECAMYLAMINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Manchester PharmaceuticalsVecamyl
Nexgen Pharma, Inc.Mecamylamine Hydrochloride
Turing PharmaceuticalsVecamyl